KYOTO, Japan , Nov. 27, 2023 /PRNewswire/ -- In a study recently published in the journal Scientific Reports, researchers from Shizuoka University, Noster Inc, and other groups in Japan identify gut-bacteria derived metabolites that ...
DUBAI , UAE , Nov. 22, 2023 /PRNewswire/ -- According to the recent report published by Kings Research, the global Population Health Management Market was valued at USD 37.23 billion in 2022 and is anticipated to reach USD 140.99 ...
A rigorous three-month longitudinal cohort study of several of flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids. BOISE, Idaho ...
CHICAGO , Nov. 21, 2023 /PRNewswire/ -- Soccer fans exhibit different patterns of brain activation while watching a match that may trigger positive and negative emotions and behaviors, according to research being presented next week at ...
CHICAGO , Nov. 20, 2023 /PRNewswire/ -- Higher amounts of visceral abdominal fat in midlife are linked to the development of Alzheimer's disease, according to research being presented next week at the annual meeting of the Radiological ...
BANGALORE, India , Nov. 3, 2023 /PRNewswire/ -- If one has been suffering from skin problems and has not been able to find a permanent solution despite medication, chances are that they have poor gut health. An observational study ...
COLD SPRING HARBOR, N.Y. , Oct. 31, 2023 /PRNewswire/ -- Order wine at a fancy restaurant, and the sommelier might describe its aroma as having notes of citrus, tropical fruit, or flowers. Yet, when you take a whiff, it might just smell ...
Latest edition of Haleon Pain Index finds half (49%) of people in pain feel stigmatised [ 1 ][ 2 ] 42% regularly feel lonely due to their pain, and one third feel serious loneliness (based on UCLA loneliness scale) [ 3 ...
NEW DELHI , Sept. 28, 2023 /PRNewswire/ -- A study conducted by National Institute for Health and Care Research (NIHR) reveals that there is no sign that e-cigarettes promote smoking. The study also found some evidence that these products ...
--Researchers found exposing cells to a small molecule drug improved their fitness during hematopoietic stem cell transplants, which could broaden access and improve outcomes for ex vivo gene therapy– PHILADELPHIA , Sept. 27, 2023 ...
Women get less restorative sleep than men because of their lifestyles and caregiving roles. They sleep less and wake up more often. A new study published in the journal Scientific Reports experimented on mice to find the sleep ...
Neonatal hypoxic-ischemic encephalopathy (HIE) is a brain dysfunction condition in newborns due to inadequate oxygen and blow flow to the brain at term or near birth. It affects 1-2 per 1,000 live births in high-resource countries . HIE is the reason for the deaths of over half a million worldwide each year. Therapeutic hypothermia is the standard treatment for moderate to severe HIE. Many infants treated with hypothermia still experience significant motor, cognitive and behavioral disabilities by school age. In low-income regions therapeutic hypothermia is unavailable and the need for new, accessible treatment is urgent. Therapies for Neuroprotection in Neonatal Hypoxic-Ischemic Encephalopathy A recent review has highlighted cutting-edge approaches to protect the newborn brain. These therapies target complex mechanisms of HIE related brain injury including inflammation, oxidative stress and cell death. Anti-excitotoxic agents like magnesium sulfate and xenon can limit brain damage caused by excessive glutamate release. Antioxidants such as allopurinol and melatonin reduce oxidative stress and improve the condition when combined with other therapies. Multi-mechanism agents like cannabidiol and caffeine promote neuroregeneration while addressing multiple pathways of injury. Stem cell therapy can repair brain damage through regenerative mechanisms. Challenges in Implementing Alternative Therapies Preclinical studies show promising results but implementing these therapies into effective clinical treatments for neonatal HIE presents many difficulties: Identifying the ideal time for administering neuroprotective therapies with the timing of hypoxic-ischemic events is important. The timing, severity and location of brain injury in hypoxic-ischemic encephalopathy can vary significantly between individuals. Need for reliable biomarkers that can assess the severity and progression of brain injury in real time, which can lead to more personalized and accurate treatment. Safe and effective delivery of these therapies to infants poses a significant challenge. Advancements in personalized medicine and combined therapies can improve treating newborns with HIE. The development of affordable and accessible treatments can revolutionize care for this life-altering condition and give hope to families. Reference: Neuroprotection for neonatal hypoxic-ischemic encephalopathy: a review of novel therapies evaluated in clinical studies- (https:...
A new study has revealed that young adults at risk of psychosis exhibit reduced brain connectivity, a deficiency that seems to be exacerbated by cannabis use. This finding opens the door for developing treatments for psychosis that address symptoms ...
Vagus nerve stimulation may help alleviate the symptoms of inflammatory bowel disease (IBD), suggests a new study. According to a team of researchers at Duke University School of Medicine, targeting the nervous system could help reduce the ...
Cardiovascular disease and dementia are major public health concerns that place a substantial strain on healthcare systems and society. A recent study from the Karolinska Institute in Sweden reveals that prolonged use of commonly prescribed ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers